Background: All of the available diagnostic tests for deep ve-nous thrombosis (DVT) have limitations for excluding acute recur-rent DVT. Measurement of plasma D-dimer by using an automated quantitative assay may be useful as a rapid exclusion test in patients with suspected recurrent DVT. Objective: To test the safety of withholding additional diagnos-tic testing and heparin treatment in patients who have a negative D-dimer result at presentation (using the automated quantitative assay STA-Liatest D-di), regardless of their symptoms. Design: Prospective cohort study. Setting: Academic medical center in the United States. Patients: 300 consecutive patients with suspected recurrent DVT. Intervention: Patients underwent D-dimer testing at pres...
Abstract Objectives: To investigate the reliability of a combined strategy of clinical assessment sc...
OBJECTIVES: To investigate the reliability of a combined strategy of clinical assessment score follo...
The optimal duration of anticoagulation in patients with venous thromboembolism (VTE) is uncertain. ...
jective testing is required to confirm or refute the diagnosis. Objective: To determine whether the ...
testing is usually considered necessary when patients present with suspected deep venous thrombosis ...
Background: Several strategies for safely excluding deep vein thrombosis (DVT) while limiting the nu...
Background: Deep venous thrombosis is a common disorder associated with significant morbidity, chron...
The optimal duration of anticoagulation after recurrent venous thromboembolism(VTE) is poorly establ...
International audienceBACKGROUND: D-dimer levels remain elevated in many patients after completion o...
AbstractConclusionk/ST>The combination of a d-dimer assay and a clinical prediction model of the pos...
Background: D-Dimer testing is sensitive but not specific for diag-nosing deep venous thrombosis (DV...
BACKGROUND: D-dimer levels remain elevated in many patients after completion of a 6-month anticoagul...
Background Current guidelines recommend the use of clinical decision rules, such as Wells score, in...
tive predictive values for the diagnosis of deep venous thrombosis, their accuracy in patients with ...
Objectives:To assess the applicability of plasma D-dimer levels in the exclusion of a DVT.Design:Con...
Abstract Objectives: To investigate the reliability of a combined strategy of clinical assessment sc...
OBJECTIVES: To investigate the reliability of a combined strategy of clinical assessment score follo...
The optimal duration of anticoagulation in patients with venous thromboembolism (VTE) is uncertain. ...
jective testing is required to confirm or refute the diagnosis. Objective: To determine whether the ...
testing is usually considered necessary when patients present with suspected deep venous thrombosis ...
Background: Several strategies for safely excluding deep vein thrombosis (DVT) while limiting the nu...
Background: Deep venous thrombosis is a common disorder associated with significant morbidity, chron...
The optimal duration of anticoagulation after recurrent venous thromboembolism(VTE) is poorly establ...
International audienceBACKGROUND: D-dimer levels remain elevated in many patients after completion o...
AbstractConclusionk/ST>The combination of a d-dimer assay and a clinical prediction model of the pos...
Background: D-Dimer testing is sensitive but not specific for diag-nosing deep venous thrombosis (DV...
BACKGROUND: D-dimer levels remain elevated in many patients after completion of a 6-month anticoagul...
Background Current guidelines recommend the use of clinical decision rules, such as Wells score, in...
tive predictive values for the diagnosis of deep venous thrombosis, their accuracy in patients with ...
Objectives:To assess the applicability of plasma D-dimer levels in the exclusion of a DVT.Design:Con...
Abstract Objectives: To investigate the reliability of a combined strategy of clinical assessment sc...
OBJECTIVES: To investigate the reliability of a combined strategy of clinical assessment score follo...
The optimal duration of anticoagulation in patients with venous thromboembolism (VTE) is uncertain. ...